Clinical trial
Percutaneous Treatment of Very LONG Native Coronary Lesions With Drug-Eluting Stent-VI: Everolimus-eluting Versus Zotarolimus-Eluting Stents
NCT01489761 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Percutaneous Treatment of Very LONG Native Coronary Lesions With Drug-Eluting Stent-VI: Everolimus-eluting Versus Zotarolimus-Eluting Stents
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2012
- Completion date
- February 14, 2017
- Enrollment
- 302 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.